Oral delivery of therapeutic proteins and peptides: a review on recent developments.
about
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesLong-term delivery of protein therapeuticsRecent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticlesA novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock.pH-Responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein deliveryDesigning DNA nanodevices for compatibility with the immune system of higher organismsSARS Coronavirus Fusion Peptide-Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice.Functionalized Graphene Oxide with Chitosan for Protein Nanocarriers to Protect against Enzymatic Cleavage and Retain Collagenase Activity.Comparative evaluation of recombinant protein production in different biofactories: the green perspective.Oral peptide and protein delivery: intestinal obstacles and commercial prospects.Planar bioadhesive microdevices: a new technology for oral drug delivery.Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery.Biocompatibility and Stability of Polysaccharide Polyelectrolyte Complexes Aimed at Respiratory Delivery.Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.Rationally designed ligand-independent peptide inhibitors of TREM-1 ameliorate collagen-induced arthritis.Influence of molecular weight and degree of deacetylation of low molecular weight chitosan on the bioactivity of oral insulin preparations.Protein-loaded emulsion electrospun fibers optimized for bioactivity retention and pH-controlled release for peroral delivery of biologic therapeutics.Enhanced oral bioavailability of salmeterol by loaded PLGA microspheres: preparation, in vitro, and in vivo evaluation.Alginate-containing systems for oral delivery of superoxide dismutase. Comparison of various configurations and their properties.Solution and solid state conformational preferences of a family of cyclic disulphide bridged tetrapeptides.Thoughts on the progression of type 2 diabetes drug discovery.Polymeric lipid vesicles with pH-responsive turning on-off membrane for programed delivery of insulin in GI tract.Controlled release from protein particles encapsulated by molecular layer deposition.Impact of the in vitro gastrointestinal passage of biopolymer-based nanoparticles on insulin absorption
P2860
Q26744008-50C5C848-C59F-4752-A50E-30EBE85BABD4Q26860505-49E0050F-61A5-469C-9D96-3EC371E0F542Q27028129-C4B443F6-FD37-4942-80E5-0EB575A168C4Q33869944-3C98FFB8-A1A4-4630-BF8F-14D0B87039D1Q33894838-0499E3FC-9F6D-49C1-A6F6-C34F24E8764EQ33902253-3E4AB52A-9251-4BB7-B510-64A941EDE7A6Q36525019-44938AEA-5C0A-466E-B351-241A83AB1037Q36888146-48464DFD-4F3B-4460-97A5-5A134B488A9CQ37044451-D432E8CF-1F0D-4AE5-9A10-9D5BA0383D9DQ37635372-EDB51559-6165-48CB-B820-81065AE8EE4AQ37679720-72755737-FF48-4D28-BAE3-AB2F2A912610Q38210847-77F4DBCA-6F4A-4A43-9ACE-1DCF16DA6348Q38248999-9A395D60-26AF-4011-B7FF-3A4C72C4CDB0Q38267521-BCA52CDF-B414-459E-8037-EEA04F2714EFQ39036547-F67A9DC0-FBE8-4E62-BA00-52A7E3431DB7Q41029569-7B9313D6-000A-4C99-8AC4-93FED8CD879BQ41365905-8E9CDCE5-1B42-4C1E-A9F7-98B3A513C6E8Q42030573-84B291CB-D9EE-4EA4-98F1-8D72648F804DQ42583522-66C79D45-7F46-4A09-9D1C-3EE42C9BC8E1Q47754482-B6F606F2-35DA-4852-BF2F-EEB1BC7862F2Q51087870-2943ED70-70BB-4C9A-9580-B2B8E6634BB2Q51279263-D08B926C-42BF-465A-A5C7-6022952E8236Q51528281-8961C576-A17D-42A3-BA7B-FCAE9E7BA65AQ52980626-BF7D96AE-27A6-40F3-BD46-3F91B89AFF2DQ53019666-7BC43175-3CA0-476E-A264-DEF05BD50E76Q53188200-C89F89C1-88E8-4B1D-8BBF-AB98683FEF1EQ57570696-6D4E88D5-6884-4BCE-A6CF-C1758063897A
P2860
Oral delivery of therapeutic proteins and peptides: a review on recent developments.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Oral delivery of therapeutic proteins and peptides: a review on recent developments.
@en
type
label
Oral delivery of therapeutic proteins and peptides: a review on recent developments.
@en
prefLabel
Oral delivery of therapeutic proteins and peptides: a review on recent developments.
@en
P2093
P2860
P1433
P1476
Oral delivery of therapeutic proteins and peptides: a review on recent developments.
@en
P2093
Arushi Jain
Jasjeet K Sahni
Mainak Chakraborty
Shweta Dang
Sonal Gupta
P2860
P304
P356
10.3109/10717544.2013.819611
P407
P50
P577
2013-08-01T00:00:00Z